Please login to the form below

Not currently logged in
Email:
Password:

NeuroTherm appoints Gregory Cash as president and CEO

Joins pain management device manufacturers from HeartSine

Gregory Cash has been appointed president and CEO of US-based pain management device company NeuroTherm.

He joins from HeartSine Technologies, where he also served as president and CEO.

“This is a key appointment at an important time for NeuroTherm, and we are certain that Greg's leadership combined with his strategic vision  and experience make him the right person to lead the company through the next phase of rapid growth and development,” said Eric Bacon, chair of the board of directors at NeuroTherm.

Prior to his time at HeartSine, Cash served in numerous senior management roles of progressive responsibility in the US, Asia and Europe.

“While there are many challenges facing the medical device industry as a whole, NeuroTherm is poised for strong growth and will continue to make a positive difference in patients' lives,” said Cash.

24th September 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Galbraith Wight

The GalbraithWight Business School deliver boths in-house and public training programmes including the only accredited diploma designed specifically to enable...

Latest intelligence

Online Physician Communities
M3 and partners win Digital Sales Aid Award
Wins for campaign to overcome limited doctor engagement with pharma-owned websites...
UK Customer Experience Awards 2014 Highlights
Stephanie Hall, Managing Director at Uptake Strategies, attended this year’s cross-industry UK Customer Experience Awards as a member of the judging panel for Business Transformation....
McCann3-thumb.jpg
The heart of the matter - Part Three
Is pharma doing enough to maximise real world evidence?...